Identifying key genes and functionally enriched pathways in acute myeloid leukemia by weighted gene co-expression network analysis
- PMID: 38977582
- DOI: 10.1007/s13353-024-00881-0
Identifying key genes and functionally enriched pathways in acute myeloid leukemia by weighted gene co-expression network analysis
Abstract
Acute myeloid leukemia (AML) is characterized by the uncontrolled proliferation of myeloid leukemia cells in the bone marrow and other hematopoietic tissues and is highly heterogeneous. While with the progress of sequencing technology, understanding of the AML-related biomarkers is still incomplete. The purpose of this study is to identify potential biomarkers for prognosis of AML. Based on WGCNA analysis of gene mutation expression, methylation level distribution, mRNA expression, and AML-related genes in public databases were employed for investigating potential biomarkers for the prognosis of AML. This study screened a total of 6153 genes by analyzing various changes in 103 acute myeloid leukemia (AML) samples, including gene mutation expression, methylation level distribution, mRNA expression, and AML-related genes in public databases. Moreover, seven AML-related co-expression modules were mined by WGCNA analysis, and twelve biomarkers associated with the AML prognosis were identified from each top 10 genes of the seven co-expression modules. The AML samples were then classified into two subgroups, the prognosis of which is significantly different, based on the expression of these twelve genes. The differentially expressed 7 genes of two subgroups (HOXB-AS3, HOXB3, SLC9C2, CPNE8, MEG8, S1PR5, MIR196B) are mainly involved in glucose metabolism, glutathione biosynthesis, small G protein-mediated signal transduction, and the Rap1 signaling pathway. With the utilization of WGCNA mining, seven gene co-expression modules were identified from the TCGA database, and there are unreported genes that may be potential driver genes of AML and may be the direction to identify the possible molecular signatures to predict survival of AML patients and help guide experiments for potential clinical drug targets.
Keywords: Acute myeloid leukemia (AML); Biomarker; Prognosis; TCGA (The Cancer Genome Atlas); Weight gene co-expression network analysis (WGCNA).
© 2024. The Author(s), under exclusive licence to Institute of Plant Genetics Polish Academy of Sciences.
Conflict of interest statement
Declarations. Ethics approval: Since this was a planning study without any delivery to any patient, there was no ethical approval required for this study. Consent for publication: That the article is original, has already been published in a preprint copy https://doi.org/10.21203/rs.3.rs-29046/v1 ( https://doi.org/10.21203/rs.3.rs-29046/v1 ), and is not currently under consideration by another journal. Competing interests: The authors declare no competing interests.
Similar articles
-
Identification of two key biomarkers CD93 and FGL2 associated with survival of acute myeloid leukaemia by weighted gene co-expression network analysis.J Cell Mol Med. 2024 Jul;28(14):e18552. doi: 10.1111/jcmm.18552. J Cell Mol Med. 2024. PMID: 39054581 Free PMC article.
-
Identification of Potential Biomarkers and Pathways in Acute Myeloid Leukemia: Correlation Between the Calcineurin Signaling Pathway and Vascular Brittleness in Acute Myeloid Leukemia.Int J Lab Hematol. 2025 Apr;47(2):288-296. doi: 10.1111/ijlh.14410. Epub 2024 Dec 5. Int J Lab Hematol. 2025. PMID: 39638778
-
Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data.BMC Med Genomics. 2021 Feb 3;14(1):39. doi: 10.1186/s12920-021-00888-0. BMC Med Genomics. 2021. PMID: 33536020 Free PMC article.
-
Decoding Acute Myeloid Leukemia: A Clinician's Guide to Functional Profiling.Diagnostics (Basel). 2024 Nov 14;14(22):2560. doi: 10.3390/diagnostics14222560. Diagnostics (Basel). 2024. PMID: 39594226 Free PMC article. Review.
-
Genomics of acute myeloid leukemia.Cancer J. 2011 Nov-Dec;17(6):487-91. doi: 10.1097/PPO.0b013e31823c5652. Cancer J. 2011. PMID: 22157292 Free PMC article. Review.
Cited by
-
Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives.Int J Mol Sci. 2025 Aug 5;26(15):7547. doi: 10.3390/ijms26157547. Int J Mol Sci. 2025. PMID: 40806675 Free PMC article. Review.
-
Identification and functional analysis of GNAI1 as a biomarker associated with immune-related genes in pediatric acute myeloid leukemia.Transl Cancer Res. 2025 May 30;14(5):2858-2873. doi: 10.21037/tcr-24-1595. Epub 2025 May 23. Transl Cancer Res. 2025. PMID: 40530109 Free PMC article.
References
-
- Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11:1–12 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical